LAROTRECTINIB

LAROTRECTINIB was reported 896 times

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NTRK GENE FUSION OVEREXPRESSION 1 0.5000
1 NTRK GENE FUSION CANCER 2 0.5000
2 MALIGNANT NEOPLASM OF RETINA 1 0.3333
3 CONGENITAL FIBROSARCOMA 1 0.3333
4 NTRK GENE FUSION POSITIVE 1 0.3333
5 NASAL ASPIRATION 1 0.2500
6 MESOBLASTIC NEPHROMA 1 0.1250
7 FIBROSARCOMA METASTATIC 1 0.0909
8 SALIVARY GLAND CANCER RECURRENT 1 0.0667
9 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0513
10 UPPER AIRWAY NECROSIS 1 0.0500
11 PAROXYSMAL EXTREME PAIN DISORDER 1 0.0400
12 BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC 1 0.0345
13 DESMOPLASTIC SMALL ROUND CELL TUMOUR 3 0.0345
14 METASTATIC SALIVARY GLAND CANCER 1 0.0278
15 DEDIFFERENTIATED LIPOSARCOMA 1 0.0250
16 NERVOUS SYSTEM NEOPLASM 1 0.0213
17 MALIGNANT GLIOMA 3 0.0211
18 SALIVARY GLAND ADENOMA 1 0.0208
19 ABDOMINAL INCARCERATED HERNIA 1 0.0200
20 GLIONEURONAL TUMOUR 1 0.0185
21 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 1 0.0185
22 MYXOFIBROSARCOMA 1 0.0185
23 UVEAL MELANOMA 1 0.0179
24 TRANSDIFFERENTIATION OF NEOPLASM 1 0.0172
25 CEREBRAL MICROINFARCTION 1 0.0172
26 MENINGIOMA MALIGNANT 1 0.0164
27 ADENOID CYSTIC CARCINOMA 2 0.0156
28 ASTROCYTOMA 6 0.0152
29 NEUROENDOCRINE CARCINOMA OF PROSTATE 1 0.0147
30 TRANSAMINASES DECREASED 1 0.0147
31 ASSISTED SUICIDE 1 0.0143
32 FEMORAL HERNIA INCARCERATED 1 0.0139
33 LUNG SQUAMOUS CELL CARCINOMA METASTATIC 1 0.0135
34 FIBROSARCOMA 1 0.0127
35 UTERINE LEIOMYOSARCOMA 1 0.0125
36 HYPOPHARYNGEAL CANCER 1 0.0119
37 ASTROCYTOMA, LOW GRADE 2 0.0118
38 BLOOD CHOLINESTERASE INCREASED 1 0.0116
39 DRUG RESISTANCE MUTATION 2 0.0112
40 GLIOMA 7 0.0109
41 GLIOBLASTOMA MULTIFORME 9 0.0107
42 SYNOVIAL SARCOMA 1 0.0105
43 VASCULAR NEOPLASM 1 0.0099
44 SARCOMA 11 0.0097
45 NEUROFIBROSARCOMA 1 0.0097
46 ASTROCYTOMA MALIGNANT 1 0.0097
47 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 1 0.0095
48 GAIT DEVIATION 1 0.0093
49 MALIGNANT MEDIASTINAL NEOPLASM 1 0.0091
50 PANCREATIC LEAK 1 0.0089
51 VENTRICULO-PERITONEAL SHUNT 1 0.0088
52 PLEURAL CALCIFICATION 1 0.0087
53 SOFT TISSUE SARCOMA 3 0.0086
54 OLIGODENDROGLIOMA 1 0.0083
55 ANAPLASTIC THYROID CANCER 1 0.0083
56 GLIOBLASTOMA 14 0.0082
57 SALIVARY GLAND CANCER 4 0.0081
58 SARCOMA UTERUS 1 0.0078
59 INFLAMMATORY MYOFIBROBLASTIC TUMOUR 1 0.0077
60 CYTOKINE INCREASED 1 0.0074
61 SPINDLE CELL SARCOMA 1 0.0074
62 SARCOMA METASTATIC 1 0.0072
63 THYROID CANCER METASTATIC 2 0.0071
64 HYPERCAPNIC COMA 1 0.0070
65 NEUROFIBROMA 1 0.0067
66 IMMUNE-MEDIATED NEUROPATHY 1 0.0065
67 HEAD CIRCUMFERENCE ABNORMAL 1 0.0065
68 BONE FORMATION DECREASED 1 0.0063
69 BLOOD CALCITONIN INCREASED 1 0.0061
70 ANAPLASTIC ASTROCYTOMA 1 0.0061
71 PELVIC NEOPLASM 2 0.0058
72 TRACHEAL HAEMORRHAGE 2 0.0057
73 GROWTH ACCELERATED 1 0.0046
74 SALIVARY GLAND PAIN 1 0.0046
75 CHOLELITHOTOMY 1 0.0046
76 TRACHEAL OBSTRUCTION 1 0.0038
77 HEMIANAESTHESIA 3 0.0038
78 THORACIC CAVITY DRAINAGE 1 0.0037
79 ABDOMINAL WOUND DEHISCENCE 1 0.0037
80 NON-SMALL CELL LUNG CANCER RECURRENT 1 0.0035
81 SALIVARY GLAND NEOPLASM 1 0.0035
82 ALOPECIA UNIVERSALIS 1 0.0034
83 DOSE CALCULATION ERROR 2 0.0034
84 EXTRAPULMONARY TUBERCULOSIS 1 0.0034
85 PHARYNGEAL OPERATION 1 0.0031
86 HEART RATE 1 0.0029
87 NONINFECTIVE ENCEPHALITIS 2 0.0028
88 CERVICAL CORD COMPRESSION 1 0.0028
89 OSTEOSARCOMA 1 0.0026
90 LEIOMYOSARCOMA 1 0.0026
91 HAEMORRHAGIC CYST 1 0.0026
92 DROPPED HEAD SYNDROME 1 0.0025
93 VITAMIN K DEFICIENCY 1 0.0025
94 TUMOUR ASSOCIATED FEVER 1 0.0024
95 FRACTURE DISPLACEMENT 1 0.0023
96 PAPILLARY THYROID CANCER 4 0.0023
97 FOOD REFUSAL 2 0.0023
98 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
99 ANGIOSARCOMA 1 0.0022
100 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
101 INTRACRANIAL MASS 2 0.0021
102 PRODUCT DOSAGE FORM ISSUE 1 0.0021
103 TUMOUR INVASION 1 0.0021
104 BODY HEIGHT INCREASED 1 0.0020
105 PROTEIN-LOSING GASTROENTEROPATHY 1 0.0020
106 METASTASES TO BONE MARROW 1 0.0020
107 TUMOUR NECROSIS 2 0.0019
108 ORTHOSTATIC HYPERTENSION 1 0.0017
109 ALLODYNIA 2 0.0017
110 SUPERIOR VENA CAVA SYNDROME 1 0.0017
111 MEAN PLATELET VOLUME INCREASED 1 0.0017
112 RECTAL ADENOCARCINOMA 1 0.0017
113 METASTASES TO PELVIS 1 0.0016
114 PERNICIOUS ANAEMIA 1 0.0016
115 PERITONEAL DISORDER 1 0.0015
116 CELL DEATH 3 0.0015
117 HEAD AND NECK CANCER 1 0.0015
118 DERMATITIS DIAPER 1 0.0014
119 PANCREATIC CARCINOMA METASTATIC 4 0.0014
120 LUNG CANCER METASTATIC 4 0.0014
121 TRAUMATIC FRACTURE 1 0.0014
122 LUNG ADENOCARCINOMA 4 0.0013
123 METASTASES TO MENINGES 3 0.0013
124 NEUROLOGICAL DECOMPENSATION 3 0.0013
125 PRODUCT INEFFECTIVE 1 0.0013
126 BRONCHIAL CARCINOMA 1 0.0013
127 EYELID FUNCTION DISORDER 1 0.0013
128 RETICULOCYTE COUNT INCREASED 1 0.0012
129 RENAL ABSCESS 1 0.0012
130 CARDIAC STRESS TEST ABNORMAL 1 0.0012
131 ENTEROVIRUS INFECTION 1 0.0012
132 ABDOMINAL SEPSIS 1 0.0011
133 METASTASES TO LUNG 13 0.0011
134 OCCUPATIONAL EXPOSURE TO PRODUCT 7 0.0011
135 HYPERVIGILANCE 1 0.0010
136 PYURIA 1 0.0010
137 GENE MUTATION 2 0.0010
138 ULNA FRACTURE 1 0.0010
139 METASTASES TO SKIN 1 0.0010
140 METASTASES TO PLEURA 1 0.0010
141 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
142 BONE NEOPLASM 1 0.0009
143 ADENOCARCINOMA 2 0.0009
144 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
145 COLORECTAL CANCER METASTATIC 2 0.0008
146 NEPHROCALCINOSIS 1 0.0008
147 BILE DUCT STENOSIS 1 0.0008
148 HAEMATOMA MUSCLE 1 0.0008
149 MONOCYTE COUNT DECREASED 1 0.0008
150 PANCREATIC NEOPLASM 1 0.0008
151 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
152 METASTASES TO PERITONEUM 2 0.0008
153 DRUG RESISTANCE 20 0.0008
154 OBSTRUCTION GASTRIC 1 0.0008
155 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
156 TUMOUR PAIN 1 0.0008
157 GASTROENTERITIS NOROVIRUS 1 0.0008
158 ABDOMINAL MASS 2 0.0007
159 THYROID NEOPLASM 2 0.0007
160 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
161 NEUROENDOCRINE TUMOUR 1 0.0007
162 AUDITORY DISORDER 1 0.0007
163 TUMOUR HAEMORRHAGE 2 0.0007
164 MUTISM 1 0.0007
165 GALLBLADDER CANCER 1 0.0007
166 SENSITIVE SKIN 5 0.0007
167 CHOLANGIOCARCINOMA 1 0.0007
168 EMERGENCY CARE 2 0.0007
169 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
170 LIVER FUNCTION TEST INCREASED 14 0.0007
171 MULTIPLE-DRUG RESISTANCE 2 0.0006
172 LIMB DEFORMITY 1 0.0006
173 HEPATIC CYTOLYSIS 8 0.0006
174 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
175 COLON CANCER METASTATIC 1 0.0006
176 ENTEROBACTER INFECTION 1 0.0006
177 METASTASES TO LYMPH NODES 4 0.0006
178 HEPATORENAL SYNDROME 1 0.0006
179 THYROIDECTOMY 1 0.0006
180 METASTASIS 4 0.0006
181 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
182 AMYLASE INCREASED 2 0.0005
183 LYMPH NODE PAIN 1 0.0005
184 ADENOCARCINOMA OF COLON 1 0.0005
185 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
186 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
187 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
188 TRANSAMINASES INCREASED 11 0.0005
189 EAR HAEMORRHAGE 1 0.0005
190 OSTEOLYSIS 1 0.0005
191 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
192 NEUROGENIC BLADDER 1 0.0005
193 NEUROPATHY PERIPHERAL 45 0.0005
194 PHARYNGEAL ERYTHEMA 1 0.0005
195 RADIATION PNEUMONITIS 1 0.0005
196 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
197 METASTATIC NEOPLASM 2 0.0005
198 JAW FRACTURE 1 0.0005
199 CEREBELLAR SYNDROME 1 0.0005
200 METASTASES TO LIVER 8 0.0005
201 PARONYCHIA 2 0.0005
202 ENDOMETRIAL CANCER 1 0.0005
203 TEMPERATURE REGULATION DISORDER 1 0.0004
204 TONGUE BLISTERING 1 0.0004
205 PERIARTHRITIS 1 0.0004
206 BILIRUBIN CONJUGATED INCREASED 1 0.0004
207 TIBIA FRACTURE 2 0.0004
208 VARICELLA 1 0.0004
209 NON-SMALL CELL LUNG CANCER 2 0.0004
210 THYROID CANCER 5 0.0004
211 INCORRECT DOSAGE ADMINISTERED 2 0.0004
212 RETINAL TEAR 1 0.0004
213 HEPATOTOXICITY 9 0.0004
214 PERSECUTORY DELUSION 1 0.0004
215 NEUROTOXICITY 7 0.0004
216 EYELID IRRITATION 1 0.0004
217 PATHOLOGICAL FRACTURE 2 0.0004
218 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
219 FAILURE TO THRIVE 2 0.0004
220 URINE OUTPUT INCREASED 1 0.0004
221 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
222 HEPATIC FUNCTION ABNORMAL 14 0.0004
223 COMPRESSION FRACTURE 2 0.0004
224 HYDROCEPHALUS 2 0.0004
225 METASTASES TO BONE 6 0.0004
226 PLEURITIC PAIN 1 0.0004
227 ENDOTRACHEAL INTUBATION 1 0.0004
228 OXYGEN SATURATION ABNORMAL 1 0.0004
229 SKIN WARM 2 0.0003
230 BILIARY COLIC 1 0.0003
231 HYPOAESTHESIA ORAL 5 0.0003
232 DYSAESTHESIA 1 0.0003
233 RESPIRATORY DISTRESS 9 0.0003
234 FIBROSIS 1 0.0003
235 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
236 DISEASE PROGRESSION 38 0.0003
237 PANCREATIC CARCINOMA STAGE IV 1 0.0003
238 ORTHOPNOEA 1 0.0003
239 LYMPHOCYTE COUNT INCREASED 1 0.0003
240 TASTE DISORDER 6 0.0003
241 EYE MOVEMENT DISORDER 2 0.0003
242 WOUND COMPLICATION 1 0.0003
243 REGURGITATION 1 0.0003
244 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
245 NECROTISING FASCIITIS 1 0.0003
246 JAUNDICE CHOLESTATIC 1 0.0003
247 GLOSSITIS 1 0.0003
248 MONOCYTE COUNT INCREASED 1 0.0003
249 SPONDYLITIS 1 0.0003
250 GAIT INABILITY 9 0.0003
251 COLON CANCER 4 0.0003
252 INTESTINAL PERFORATION 3 0.0003
253 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
254 HEPATOCELLULAR CARCINOMA 2 0.0003
255 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
256 FAECES HARD 1 0.0003
257 SPINAL CORD COMPRESSION 1 0.0003
258 TESTIS CANCER 1 0.0003
259 MULTIPLE ALLERGIES 2 0.0003
260 NAIL DISCOLOURATION 1 0.0003
261 THERAPY CESSATION 13 0.0003
262 POLYDIPSIA 1 0.0003
263 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
264 ATAXIA 3 0.0003
265 HYPERPHAGIA 1 0.0003
266 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
267 RECURRENT CANCER 1 0.0002
268 CYTOPENIA 3 0.0002
269 MULTIPLE FRACTURES 4 0.0002
270 PANCREATIC CARCINOMA 7 0.0002
271 SELF-INJURIOUS IDEATION 1 0.0002
272 ONYCHOMADESIS 1 0.0002
273 HALLUCINATIONS, MIXED 1 0.0002
274 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
275 MUSCLE FATIGUE 1 0.0002
276 TONGUE DISCOMFORT 1 0.0002
277 LUNG NEOPLASM 1 0.0002
278 SHOULDER OPERATION 1 0.0002
279 PRODUCT DISPENSING ISSUE 1 0.0002
280 HEPATIC LESION 1 0.0002
281 BONE CANCER 1 0.0002
282 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
283 BRAIN NEOPLASM MALIGNANT 1 0.0002
284 HEPATIC ENZYME INCREASED 15 0.0002
285 URINE ABNORMALITY 1 0.0002
286 DISEASE COMPLICATION 1 0.0002
287 EAR DISORDER 1 0.0002
288 BRAIN NEOPLASM 2 0.0002
289 SYNOVIAL CYST 1 0.0002
290 RENAL FUNCTION TEST ABNORMAL 1 0.0002
291 WITHDRAWAL SYNDROME 9 0.0002
292 HEPATIC ENCEPHALOPATHY 2 0.0002
293 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
294 HEPATOCELLULAR INJURY 3 0.0002
295 CARDIAC TAMPONADE 1 0.0002
296 TUMOUR MARKER INCREASED 1 0.0002
297 GASTROINTESTINAL TOXICITY 1 0.0002
298 DIZZINESS POSTURAL 2 0.0002
299 ASCITES 6 0.0002
300 THERAPY CHANGE 2 0.0002
301 INFLAMMATORY MARKER INCREASED 1 0.0002
302 NEOPLASM PROGRESSION 7 0.0002
303 HYPERNATRAEMIA 1 0.0002
304 HEPATIC ENZYME ABNORMAL 1 0.0002
305 HYPOTONIA 2 0.0002
306 FLUID INTAKE REDUCED 1 0.0002
307 DERMATITIS EXFOLIATIVE 1 0.0002
308 MOTOR DYSFUNCTION 2 0.0002
309 HEPATITIS 5 0.0002
310 CACHEXIA 1 0.0002
311 CEREBRAL ISCHAEMIA 1 0.0002
312 TEMPERATURE INTOLERANCE 2 0.0002
313 MALABSORPTION 1 0.0002
314 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
315 BREAST CANCER METASTATIC 2 0.0002
316 JAUNDICE 5 0.0002
317 BLOOD BILIRUBIN INCREASED 5 0.0002
318 PULMONARY THROMBOSIS 2 0.0002
319 TIC 1 0.0002
320 FAECALOMA 1 0.0002
321 AUTISM SPECTRUM DISORDER 1 0.0002
322 CHOKING SENSATION 1 0.0002
323 FEELING COLD 5 0.0002
324 INTRACRANIAL PRESSURE INCREASED 1 0.0002
325 NEUTROPHILIA 1 0.0002
326 NEUROLOGICAL SYMPTOM 1 0.0002
327 ENTEROCOLITIS 1 0.0002
328 HYPERVENTILATION 1 0.0002
329 SPINAL PAIN 2 0.0002
330 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
331 LUNG NEOPLASM MALIGNANT 7 0.0002
332 NEURALGIA 4 0.0002
333 CARDIOMEGALY 2 0.0002
334 CHOLANGITIS 1 0.0002
335 PRE-EXISTING CONDITION IMPROVED 1 0.0002
336 MYALGIA 27 0.0002
337 BRAIN OEDEMA 2 0.0002
338 INCREASED APPETITE 3 0.0002
339 CHOLESTASIS 3 0.0002
340 ASPERGILLUS INFECTION 1 0.0002
341 CARDIAC FAILURE ACUTE 1 0.0001
342 FEEDING DISORDER 3 0.0001
343 PULMONARY EMBOLISM 14 0.0001
344 TACHYPNOEA 2 0.0001
345 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
346 JOINT EFFUSION 1 0.0001
347 COORDINATION ABNORMAL 2 0.0001
348 DERMATITIS 3 0.0001
349 LUNG DISORDER 7 0.0001
350 PULMONARY TOXICITY 1 0.0001
351 HAND FRACTURE 1 0.0001
352 PRODUCT SUPPLY ISSUE 1 0.0001
353 HYPERSOMNIA 4 0.0001
354 PANIC REACTION 1 0.0001
355 BLOOD CREATININE INCREASED 9 0.0001
356 FLUID RETENTION 7 0.0001
357 RESPIRATORY FAILURE 10 0.0001
358 CARDIOMYOPATHY 2 0.0001
359 CEREBRAL DISORDER 1 0.0001
360 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
361 TROPONIN INCREASED 1 0.0001
362 LIPASE INCREASED 1 0.0001
363 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
364 HYPOALBUMINAEMIA 1 0.0001
365 ACUTE MYELOID LEUKAEMIA 2 0.0001
366 THERAPY PARTIAL RESPONDER 2 0.0001
367 NERVOUS SYSTEM DISORDER 4 0.0001
368 BRAIN FOG 2 0.0001
369 DYSPHAGIA 12 0.0001
370 FURUNCLE 1 0.0001
371 PNEUMOTHORAX 2 0.0001
372 BLOOD DISORDER 1 0.0001
373 DIZZINESS 62 0.0001
374 MUSCLE DISORDER 1 0.0001
375 SHOCK HAEMORRHAGIC 1 0.0001
376 DECUBITUS ULCER 1 0.0001
377 HYPERAESTHESIA 1 0.0001
378 ESCHERICHIA INFECTION 1 0.0001
379 PARAESTHESIA 19 0.0001
380 EMBOLISM 1 0.0001
381 HEMIPLEGIA 1 0.0001
382 EOSINOPHIL COUNT INCREASED 1 0.0001
383 NEOPLASM MALIGNANT 8 0.0001
384 PSEUDOMONAS INFECTION 1 0.0001
385 MUSCLE STRAIN 1 0.0001
386 PYELONEPHRITIS 1 0.0001
387 RESPIRATORY TRACT INFECTION 3 0.0001
388 ORTHOSTATIC HYPOTENSION 2 0.0001
389 LUNG INFILTRATION 1 0.0001
390 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
391 MYOSITIS 1 0.0001
392 MYELOSUPPRESSION 4 0.0001
393 OEDEMA 6 0.0001
394 PNEUMONITIS 3 0.0001
395 ANAEMIA 21 0.0001
396 RESTLESS LEGS SYNDROME 2 0.0001
397 C-REACTIVE PROTEIN INCREASED 4 0.0001
398 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
399 OVARIAN CANCER 1 0.0001
400 UROSEPSIS 1 0.0001
401 IRON DEFICIENCY ANAEMIA 1 0.0001
402 DYSGEUSIA 8 0.0001
403 RENAL IMPAIRMENT 9 0.0001
404 COGNITIVE DISORDER 5 0.0001
405 LEUKAEMIA 1 0.0001
406 POISONING DELIBERATE 1 0.0001
407 FEELING JITTERY 2 0.0001
408 HYPERCHOLESTEROLAEMIA 1 0.0001
409 PHARYNGEAL SWELLING 1 0.0001
410 OESOPHAGEAL CARCINOMA 3 0.0001
411 BLADDER DISORDER 1 0.0001
412 HEPATIC FAILURE 3 0.0001
413 HOSPITALISATION 15 0.0001
414 LIMB DISCOMFORT 3 0.0001
415 SKELETAL INJURY 1 0.0001
416 PETECHIAE 1 0.0001
417 KNEE ARTHROPLASTY 2 0.0001
418 SCRATCH 1 0.0001
419 HYPOAESTHESIA 14 0.0001
420 DECREASED ACTIVITY 1 0.0001
421 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
422 ASPIRATION 1 0.0001
423 DENTAL CARIES 1 0.0001
424 LIVER DISORDER 4 0.0001
425 URINARY RETENTION 3 0.0001
426 HYPERTENSIVE CRISIS 1 0.0001
427 MALNUTRITION 1 0.0001
428 NEPHROPATHY TOXIC 1 0.0001
429 STATUS EPILEPTICUS 1 0.0001
430 MITRAL VALVE INCOMPETENCE 1 0.0001
431 INTERNAL HAEMORRHAGE 1 0.0001
432 DRY MOUTH 7 0.0001
433 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
434 HYPERKALAEMIA 3 0.0001
435 SURGERY 5 0.0001
436 INFLUENZA LIKE ILLNESS 7 0.0001
437 COVID-19 PNEUMONIA 1 0.0001
438 PRODUCT PRESCRIBING ERROR 2 0.0001
439 MYOCLONUS 1 0.0001
440 CEREBRAL HAEMORRHAGE 3 0.0001
441 ACCIDENT 1 0.0001
442 HYPERLIPIDAEMIA 1 0.0001
443 POLYNEUROPATHY 1 0.0001
444 WRIST FRACTURE 1 0.0001
445 PLEURAL EFFUSION 5 0.0001
446 VERTIGO 5 0.0001
447 ABNORMAL WEIGHT GAIN 1 0.0001
448 GENERALISED OEDEMA 1 0.0001
449 THROMBOCYTOPENIA 9 0.0001
450 ILEUS 1 0.0001
451 WEIGHT INCREASED 18 0.0001
452 PNEUMONIA ASPIRATION 2 0.0001
453 LEUKOPENIA 4 0.0001
454 FATIGUE 62 0.0001
455 CONSTIPATION 17 0.0001
456 MYDRIASIS 1 0.0001
457 PLATELET COUNT INCREASED 1 0.0001
458 ABDOMINAL DISTENSION 8 0.0001
459 PRODUCT DOSE OMISSION 5 0.0001
460 PULMONARY CONGESTION 1 0.0001
461 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
462 EAR INFECTION 2 0.0001
463 MALIGNANT MELANOMA 1 0.0001
464 JOINT RANGE OF MOTION DECREASED 1 0.0001
465 QUALITY OF LIFE DECREASED 1 0.0001
466 OEDEMA PERIPHERAL 9 0.0001
467 NEUTROPHIL COUNT DECREASED 3 0.0001
468 MOOD ALTERED 2 0.0001
469 ACUTE HEPATIC FAILURE 1 0.0001
470 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
471 PERIPHERAL COLDNESS 1 0.0001
472 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
473 ORAL DISCOMFORT 1 0.0001
474 PAIN 44 0.0001
475 MASS 1 0.0001
476 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
477 PAIN IN JAW 2 0.0001
478 MUSCULAR WEAKNESS 8 0.0001
479 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
480 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
481 BALANCE DISORDER 6 0.0001
482 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
483 HYPERTHYROIDISM 1 0.0001
484 APATHY 1 0.0001
485 DYSSTASIA 2 0.0001
486 GAIT DISTURBANCE 13 0.0001
487 HAEMORRHAGE INTRACRANIAL 1 0.0001
488 RESPIRATORY DISORDER 2 0.0001
489 THERAPY NON-RESPONDER 3 0.0001
490 OSTEOPENIA 1 0.0001
491 LYMPHOMA 1 0.0001
492 DELUSION 1 0.0001
493 EJECTION FRACTION DECREASED 1 0.0001
494 PRODUCT USE COMPLAINT 1 0.0001
495 ARRHYTHMIA 3 0.0001
496 RESPIRATORY TRACT CONGESTION 1 0.0001
497 CYSTITIS 2 0.0001
498 LOSS OF CONSCIOUSNESS 8 0.0001
499 MOVEMENT DISORDER 2 0.0001
500 INTERSTITIAL LUNG DISEASE 3 0.0001
501 CONFUSIONAL STATE 10 0.0001
502 MUSCLE TIGHTNESS 1 0.0001
503 AMNESIA 4 0.0001
504 PHOTOSENSITIVITY REACTION 1 0.0001
505 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
506 DEATH 52 0.0001
507 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
508 DRY EYE 3 0.0001
509 VIRAL INFECTION 2 0.0001
510 PERICARDITIS 1 0.0001
511 HEMIPARESIS 1 0.0001
512 PERIPHERAL SWELLING 9 0.0001
513 HAEMATURIA 2 0.0001
514 MUSCULOSKELETAL DISCOMFORT 1 0.0001
515 VOMITING 27 0.0001
516 BURNING SENSATION 4 0.0001
517 HYPOXIA 2 0.0001
518 DRUG ERUPTION 1 0.0001
519 GOUT 1 0.0001
520 MOBILITY DECREASED 4 0.0001
521 SYNOVITIS 1 0.0001
522 LEUKOCYTOSIS 1 0.0001
523 HYPOTENSION 11 0.0001
524 ACCIDENTAL OVERDOSE 2 0.0001
525 HAEMATOCHEZIA 3 0.0001
526 DYSURIA 2 0.0001
527 OROPHARYNGEAL PAIN 5 0.0001
528 NECK PAIN 3 0.0001
529 PANCYTOPENIA 3 0.0001
530 HEPATIC CIRRHOSIS 1 0.0001
531 EYE PAIN 3 0.0001
532 PHOTOPHOBIA 1 0.0001
533 FRACTURE 1 0.0001
534 FOOT FRACTURE 1 0.0001
535 BLOOD URINE PRESENT 1 0.0001
536 PROTEINURIA 1 0.0001
537 MUSCULOSKELETAL DISORDER 1 0.0001
538 SLEEP APNOEA SYNDROME 1 0.0001
539 LETHARGY 3 0.0001
540 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
541 POST PROCEDURAL COMPLICATION 1 0.0001
542 ACUTE RESPIRATORY FAILURE 1 0.0001
543 SEIZURE 6 0.0001
544 HERNIA 1 0.0001
545 ERUCTATION 1 0.0001
546 NEUTROPENIA 7 0.0001
547 EAR PAIN 1 0.0001
548 CHOKING 1 0.0001
549 SKIN FISSURES 1 0.0001
550 FALL 17 0.0001
551 KIDNEY INFECTION 1 0.0001
552 WHEEZING 3 0.0001
553 DISABILITY 1 0.0001
554 SINUS DISORDER 1 0.0001
555 HAEMATOCRIT DECREASED 1 0.0001
556 BLOOD PRESSURE ABNORMAL 1 0.0001
557 UPPER LIMB FRACTURE 1 0.0001
558 IRRITABILITY 3 0.0000
559 CYTOKINE RELEASE SYNDROME 1 0.0000
560 FULL BLOOD COUNT DECREASED 1 0.0000
561 PRODUCT PHYSICAL ISSUE 1 0.0000
562 BONE MARROW FAILURE 1 0.0000
563 DISCOMFORT 3 0.0000
564 PYREXIA 17 0.0000
565 MUSCLE SPASMS 9 0.0000
566 RASH 21 0.0000
567 ARTHRALGIA 20 0.0000
568 NAUSEA 38 0.0000
569 RHABDOMYOLYSIS 2 0.0000
570 DRUG INEFFECTIVE 61 0.0000
571 MENTAL DISORDER 2 0.0000
572 PRODUCT PRESCRIBING ISSUE 1 0.0000
573 ACUTE KIDNEY INJURY 7 0.0000
574 DRUG WITHDRAWAL SYNDROME 4 0.0000
575 MELAENA 1 0.0000
576 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
577 SEPSIS 5 0.0000
578 ADVERSE DRUG REACTION 4 0.0000
579 CHROMATURIA 1 0.0000
580 PRODUCT AVAILABILITY ISSUE 1 0.0000
581 MEMORY IMPAIRMENT 6 0.0000
582 OFF LABEL USE 38 0.0000
583 SWELLING 4 0.0000
584 DISEASE RECURRENCE 2 0.0000
585 COLORECTAL CANCER 2 0.0000
586 PAIN IN EXTREMITY 12 0.0000
587 ENCEPHALOPATHY 1 0.0000
588 OSTEONECROSIS OF JAW 1 0.0000
589 VISUAL IMPAIRMENT 5 0.0000
590 AGEUSIA 1 0.0000
591 SYNCOPE 4 0.0000
592 SOMNOLENCE 8 0.0000
593 ABDOMINAL PAIN LOWER 1 0.0000
594 COUGH 11 0.0000
595 HYPOPHAGIA 1 0.0000
596 HAEMOGLOBIN DECREASED 4 0.0000
597 ABDOMINAL PAIN UPPER 8 0.0000
598 ILLNESS 4 0.0000
599 UNRESPONSIVE TO STIMULI 1 0.0000
600 EXPOSURE VIA SKIN CONTACT 1 0.0000
601 DIPLOPIA 1 0.0000
602 MUSCULOSKELETAL PAIN 2 0.0000
603 SPEECH DISORDER 2 0.0000
604 ARTHRITIS 3 0.0000
605 PANCREATITIS 2 0.0000
606 BRADYCARDIA 2 0.0000
607 BREAST CANCER FEMALE 1 0.0000
608 CARDIAC FAILURE 3 0.0000
609 PAIN OF SKIN 1 0.0000
610 THROAT TIGHTNESS 1 0.0000
611 TREATMENT FAILURE 3 0.0000
612 MENTAL STATUS CHANGES 1 0.0000
613 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
614 WOUND 1 0.0000
615 DIARRHOEA 23 0.0000
616 BLISTER 2 0.0000
617 OXYGEN SATURATION DECREASED 2 0.0000
618 FLATULENCE 2 0.0000
619 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
620 RED BLOOD CELL COUNT DECREASED 1 0.0000
621 ASTHENIA 13 0.0000
622 ABDOMINAL PAIN 8 0.0000
623 LIVER FUNCTION TEST ABNORMAL 1 0.0000
624 MUSCULOSKELETAL STIFFNESS 3 0.0000
625 PRODUCT DOSE OMISSION ISSUE 10 0.0000
626 PNEUMONIA 11 0.0000
627 LABORATORY TEST ABNORMAL 1 0.0000
628 PSYCHOTIC DISORDER 1 0.0000
629 URINARY INCONTINENCE 1 0.0000
630 RENAL INJURY 1 0.0000
631 HEADACHE 21 0.0000
632 JOINT SWELLING 4 0.0000
633 APHASIA 1 0.0000
634 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
635 EPILEPSY 1 0.0000
636 FEELING HOT 2 0.0000
637 FEMUR FRACTURE 1 0.0000
638 DRUG-INDUCED LIVER INJURY 1 0.0000
639 HEAD INJURY 1 0.0000
640 HIP FRACTURE 1 0.0000
641 DRUG INTOLERANCE 3 0.0000
642 NIGHT SWEATS 1 0.0000
643 DYSPEPSIA 3 0.0000
644 OSTEONECROSIS 1 0.0000
645 STAPHYLOCOCCAL INFECTION 1 0.0000
646 HEART RATE INCREASED 3 0.0000
647 BLOOD PRESSURE DECREASED 2 0.0000
648 EXPIRED PRODUCT ADMINISTERED 1 0.0000
649 FUNGAL INFECTION 1 0.0000
650 CEREBROVASCULAR ACCIDENT 5 0.0000
651 FEELING ABNORMAL 7 0.0000
652 COVID-19 5 0.0000
653 DYSPNOEA 16 0.0000
654 LYMPHADENOPATHY 1 0.0000
655 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
656 SKIN BURNING SENSATION 2 0.0000
657 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
658 HYPERGLYCAEMIA 1 0.0000
659 DYSARTHRIA 1 0.0000
660 DYSPNOEA EXERTIONAL 1 0.0000
661 HALLUCINATION 2 0.0000
662 HOT FLUSH 2 0.0000
663 INTESTINAL OBSTRUCTION 1 0.0000
664 COLITIS 1 0.0000
665 DECREASED APPETITE 6 0.0000
666 ABNORMAL BEHAVIOUR 1 0.0000
667 CARDIAC FAILURE CONGESTIVE 2 0.0000
668 THROMBOSIS 2 0.0000
669 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
670 DYSKINESIA 1 0.0000
671 POLLAKIURIA 1 0.0000
672 ROAD TRAFFIC ACCIDENT 1 0.0000
673 OSTEOARTHRITIS 1 0.0000
674 URINARY TRACT INFECTION 4 0.0000
675 SEPTIC SHOCK 1 0.0000
676 PRODUCT STORAGE ERROR 2 0.0000
677 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
678 ANGIOEDEMA 1 0.0000
679 PULMONARY OEDEMA 1 0.0000
680 THROAT IRRITATION 1 0.0000
681 INCORRECT DOSE ADMINISTERED 5 0.0000
682 SKIN IRRITATION 1 0.0000
683 TINNITUS 1 0.0000
684 ADVERSE EVENT 2 0.0000
685 WEIGHT DECREASED 6 0.0000
686 RENAL DISORDER 1 0.0000
687 BREAST CANCER 2 0.0000
688 COMA 1 0.0000
689 MULTIPLE SCLEROSIS 1 0.0000
690 CONTUSION 2 0.0000
691 INFECTION 3 0.0000
692 HYPOGLYCAEMIA 1 0.0000
693 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
694 AGGRESSION 1 0.0000
695 CELLULITIS 1 0.0000
696 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
697 CONDITION AGGRAVATED 6 0.0000
698 BLOOD PRESSURE INCREASED 3 0.0000
699 CHEST DISCOMFORT 2 0.0000
700 SINUSITIS 2 0.0000
701 INFLAMMATION 1 0.0000
702 HAEMORRHAGE 2 0.0000
703 DEPRESSED MOOD 1 0.0000
704 HYPERTENSION 4 0.0000
705 TREMOR 3 0.0000
706 ARTHROPATHY 1 0.0000
707 URTICARIA 3 0.0000
708 ASTHMA 2 0.0000
709 EYE IRRITATION 1 0.0000
710 MYOCARDIAL INFARCTION 3 0.0000
711 BONE PAIN 1 0.0000
712 CHILLS 2 0.0000
713 STOMATITIS 1 0.0000
714 EXPOSURE DURING PREGNANCY 1 0.0000
715 HYPERHIDROSIS 2 0.0000
716 RHINORRHOEA 1 0.0000
717 FEBRILE NEUTROPENIA 1 0.0000
718 RENAL FAILURE 2 0.0000
719 INSOMNIA 4 0.0000
720 DEHYDRATION 2 0.0000
721 DEVICE MALFUNCTION 1 0.0000
722 MALAISE 6 0.0000
723 AGITATION 1 0.0000
724 UNEVALUABLE EVENT 1 0.0000
725 ACNE 1 0.0000
726 DEPRESSION 3 0.0000
727 CHRONIC KIDNEY DISEASE 1 0.0000
728 PRURITUS 5 0.0000
729 BACK PAIN 3 0.0000
730 DRUG INTERACTION 2 0.0000
731 PROSTATE CANCER 1 0.0000
732 INTENTIONAL PRODUCT MISUSE 1 0.0000
733 TACHYCARDIA 1 0.0000
734 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
735 GASTROINTESTINAL DISORDER 1 0.0000
736 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
737 CHEST PAIN 2 0.0000
738 HYPERSENSITIVITY 2 0.0000
739 CARDIAC DISORDER 1 0.0000
740 ATRIAL FIBRILLATION 1 0.0000
741 ALOPECIA 2 0.0000
742 FLUSHING 1 0.0000
743 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
744 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
745 EMOTIONAL DISTRESS 1 0.0000
746 DRY SKIN 1 0.0000
747 VISION BLURRED 1 0.0000
748 TOXICITY TO VARIOUS AGENTS 1 0.0000
749 NASOPHARYNGITIS 1 0.0000
750 PRODUCT USE ISSUE 1 0.0000
751 BLOOD GLUCOSE INCREASED 1 0.0000
752 ERYTHEMA 1 0.0000
753 OVERDOSE 1 0.0000